Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation

Abstract

Continuous apixaban is safe and effective in patients undergoing atrial fibrillation ablation at risk of stroke with respect to bleeding, stroke, and cognitive function. Further research is needed to reduce ablation-related acute brain lesions.